Lantern Pharma annual net debt
2021
2022
2023
2024
2025
Lantern Pharma Net Debt Growth & History (LTRN)
Lantern Pharma's net debt was −$4.3M for fiscal 2025.
View full Lantern Pharma company overviewLantern Pharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$4.3M | $2.9M | — |
| 2024 | 2024-12-31 | −$7.3M | $14.4M | — |
| 2023 | 2023-12-31 | −$21.7M | $15.4M | — |
| 2022 | 2022-12-31 | −$37.1M | $14.2M | — |
| 2021 | 2021-12-31 | −$51.3M | — | — |
Lantern Pharma quarterly net debt
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$6.6M | −$704,086 | — |
| Q1 2026 | 2026-03-31 | −$4.9M | $1.5M | — |
| Q4 2025 | 2025-12-31 | −$4.3M | $2.9M | — |
| Q3 2025 | 2025-09-30 | −$8.3M | −$483,957 | — |
| Q2 2025 | 2025-06-30 | −$5.9M | $6.8M | — |
| Q1 2025 | 2025-03-31 | −$6.3M | $11.8M | — |
| Q4 2024 | 2024-12-31 | −$7.3M | $14.4M | — |
| Q3 2024 | 2024-09-30 | −$7.8M | $17.5M | — |
| Q2 2024 | 2024-06-30 | −$12.8M | $15.4M | — |
| Q1 2024 | 2024-03-31 | −$18.2M | $14.1M | — |
| Q4 2023 | 2023-12-31 | −$21.7M | $15.4M | — |
| Q3 2023 | 2023-09-30 | −$25.3M | $13.9M | — |
| Q2 2023 | 2023-06-30 | −$28.1M | $15.1M | — |
| Q1 2023 | 2023-03-31 | −$32.2M | $14.3M | — |
| Q4 2022 | 2022-12-31 | −$37.1M | $14.2M | — |
| Q3 2022 | 2022-09-30 | −$39.2M | $15.3M | — |
| Q2 2022 | 2022-06-30 | −$43.2M | $17.8M | — |
| Q1 2022 | 2022-03-31 | −$46.5M | — | — |
| Q4 2021 | 2021-12-31 | −$51.3M | — | — |
| Q3 2021 | 2021-09-30 | −$54.4M | — | — |
| Q2 2021 | 2021-06-30 | −$61.1M | — | — |
Lantern Pharma net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Lantern Pharma's net debt increased from −$51.3M to −$4.3M, a change of $47.0M. The latest reported quarter, Q2 2026, shows −$6.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lantern Pharma source filings ↗